2022 - 2
|
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B |
Yuen Man-Fung , Berliba Elina Tudor, Sukeepaisarnjaroen Wattana , Ahn Sang Hoon , Tanwandee Tawesak , Lim Young-Suk , Kim Yoon Jun , Poovorawan Kittiyod , Tangkijvanich Pisit , Schwabe Christian , Eley Timothy , Brown Joanne , Noi Autori , Gane Edward John |
1 University of Hong Kong, Hong Kong, 2 F.C.E. ARENSIA Exploratory Medicine, 3 Khon Kaen University, 4 Yonsei University, Seoul, 5 Mahidol University, Bangkok, 6 Asan Medical Center, Seoul, 7 Seoul National University, 8 Chulalongkorn University, 9 Auckland Clinical Studies, Auckland, 10 Arbutus Biopharma, Warminster, 11 University of Auckland |
Hepatology Communications |
Nr. / 2022 / ISSN 2471-254X |
Disponibil online 12 September, 2023 |
-----------------------------------------------------------------------------------------------------------------------------------